Stock Price
3.86
Daily Change
0.11 2.93%
Monthly
13.86%
Yearly
-18.74%
Q2 Forecast
3.62



Peers Price Chg Day Year Date
Avita Medical 1.10 0.02 1.86% -58.05% Apr/01
Alcidion 0.10 0.002 2.04% 21.95% Apr/01
Ansell 28.67 0.44 1.56% -16.29% Apr/01
Cochlear 175.04 5.94 3.51% -34.68% Apr/01
CSL 142.17 1.39 0.99% -44.29% Apr/01
Fisher & Paykel Healthcare 31.01 0.36 1.17% -1.49% Apr/01
Healius 0.55 -0.01 -1.79% -60.29% Apr/01
Integral Diagnostics 2.32 -0.04 -1.69% 2.20% Apr/01
Mayne Pharma 2.40 0.13 5.73% -66.81% Apr/01
Pro Medicus 123.97 7.07 6.05% -37.64% Apr/01

Indexes Price Day Year Date
ASX All Share 8886 201.66 2.32% 9.25% Apr/01

Nanosonics Ltd traded at 3.86 this Wednesday April 1st, increasing 0.11 or 2.93 percent since the previous trading session. Looking back, over the last four weeks, Nanosonics gained 13.86 percent. Over the last 12 months, its price fell by 18.74 percent. Looking ahead, we forecast Nanosonics Ltd to be priced at 3.62 by the end of this quarter and at 3.39 in one year, according to Trading Economics global macro models projections and analysts expectations.

Nanosonics Limited is an Australia-based infection prevention company. The Company''s principal activities include the manufacturing and distribution of the trophon ultrasound probe disinfector and its associated consumables and accessories. It is focused on the research, development, and commercialization of infection control and decontamination products and related technologies. Trophon technology includes high-frequency ultrasonic vibrations that generate a sonically activated hydrogen peroxide (H2O2) mist that kills bacteria, fungi, and viruses. Its products include trophon2, Nanosonics Auditpro, and trophon EPR. The Company''s trophon2 includes AcuTrace radio frequency identification (RFID) technology, which enables digital record keeping and captures disinfection data. Nanosonics AuditPro is an automated digital system that combines clinician infection prevention decision making, with the Trophon 2 device infection control workflow data, and patient procedure information.